CTEV
Claritev Corporation
NYSE · Healthcare · Medical - Healthcare Information Services · US
$38.43
−1.69%Year over year
Reported trailing growth
- Revenue
- +6.3%
- EBITDA
- +2890.6%
- EBIT
- +113.8%
- EPS
- +58.4%
- Free cash flow
- +67.8%
- Operating cash flow
- +90.1%
Forward estimates
Based on analyst estimates
- Revenue
- +4.4%
- EBITDA
- +34.7%
- EPS
- +15.9%
Three-year CAGR
- Revenue
- -3.7%
- EBITDA
- +44.3%
- EBIT
- -47.3%
- Net income
- +82.7%
- EPS
- +83.0%
- Free cash flow
- -16.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026